Skip to content
PICO Portalanswers from OpenAlex

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells

PaperCitations, authors & open-access status

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells is a paper indexed in PICO Portal from OpenAlex.

How many citations does Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells have?

PICO Portalcitation count

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells has 182 citations in the OpenAlex counts PICO Portal stores.

When was Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells published?

PICO Portalyear

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells has 2003 year in the PICO Portal index.

What is the open-access status of Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells?

PICO Portaloa status

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells has closed oa status in the PICO Portal index.

What is the DOI of Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells?

PICO Portaldoi

The DOI for Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells is on the source record.

What is the PMID of Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells?

PICO Portalpmid

The PMID for Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells is on the source record.

What is the OpenAlex record for Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells?

PICO Portalopenalex

The OpenAlex for Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial